Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Minority Interest: 2021-2025

Historic Minority Interest for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to $443.1 million.

  • Roivant Sciences' Minority Interest rose 3.76% to $443.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $443.1 million, marking a year-over-year increase of 3.76%. This contributed to the annual value of $499.6 million for FY2025, which is 4.09% up from last year.
  • According to the latest figures from Q3 2025, Roivant Sciences' Minority Interest is $443.1 million, which was down 5.77% from $470.3 million recorded in Q2 2025.
  • Over the past 5 years, Roivant Sciences' Minority Interest peaked at $499.6 million during Q1 2025, and registered a low of $234.2 million during Q2 2021.
  • Moreover, its 3-year median value for Minority Interest was $449.8 million (2023), whereas its average is $442.9 million.
  • In the last 5 years, Roivant Sciences' Minority Interest skyrocketed by 58.52% in 2022 and then decreased by 29.97% in 2024.
  • Roivant Sciences' Minority Interest (Quarterly) stood at $381.5 million in 2021, then increased by 23.61% to $471.6 million in 2022, then grew by 4.92% to $494.8 million in 2023, then fell by 29.97% to $346.5 million in 2024, then climbed by 3.76% to $443.1 million in 2025.
  • Its Minority Interest was $443.1 million in Q3 2025, compared to $470.3 million in Q2 2025 and $499.6 million in Q1 2025.